Galena Biopharma to Present at the 12th Annual BIO Investor Forum

Galena Biopharma to Present at the 12th Annual BIO Investor Forum

PORTLAND, Ore., Oct. 4, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma
(Nasdaq:GALE), a biopharmaceutical company developing and commercializing
innovative, targeted oncology treatments that address major unmet medical
needs to advance cancer care, today announced that Mark W. Schwartz, Ph.D.,
Executive Vice President and Chief Operating Officer will present a corporate
update at the 12^th Annual BIO Investor Forum. The presentation will take
place on Wednesday, October 9, 2013 at 9:00 a.m. PT at The Palace Hotel in San
Francisco, CA.

About Galena Biopharma

Galena Biopharma, Inc. (Nasdaq:GALE) is a Portland, Oregon-based
biopharmaceutical company developing and commercializing innovative, targeted
oncology treatments that address major unmet medical needs to advance cancer
care. For more information please visit www.galenabiopharma.com.

CONTACT: Remy Bernarda
         Senior Director, Communications
         (503) 405-8258
         rbernarda@galenabiopharma.com

Galena Biopharma, Inc.
 
Press spacebar to pause and continue. Press esc to stop.